About: Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Paolo Verdecchia et al published August 2005 in Hypertension

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2005 (uk) im August 2005 veröffentlichter wissenschaftlicher Artikel (de) article by Paolo Verdecchia et al published August 2005 in Hypertension (en)
publication date	wds:Q57085525-D0DE629B-F35D-45A9-B1CA-4B6D6FC1C552
publication date	2005-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57085525-1B5DDBDC-ABFB-41C6-9D1E-791F493C2AD2
language of work or name	English
author name string	wds:Q57085525-05B102C1-A347-499D-BA1B-1FE2EB332E6C wds:Q57085525-0AE3C67B-DB91-4E61-9E23-152AA5644D10 wds:Q57085525-0F11EC36-FE55-4DBC-A41E-8A489DFB7EED wds:Q57085525-9F07C47E-A499-4F80-9FC1-1BC890A83768 wds:Q57085525-D81FBAF9-1BCF-48B6-971B-47CD7D3E37F1
author name string	Fabio Angeli Paolo Verdecchia Carlo Porcellati Roberto Gattobigio Maurizio Bentivoglio
rdfs:label	Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (en) Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (nl)
skos:prefLabel	Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (en) Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (nl)
name	Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (en) Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (nl)
author	wds:Q57085525-2D1529B3-8005-4114-8B78-1EC35E65C315 wds:Q57085525-8BF201AE-11C5-421E-9A09-9043DE22F4D4 wds:Q57085525-D35803B1-0714-46FD-BAD5-FF4F80FEFB19
author	Jan A. Staessen Lutgarde Thijs Gianpaolo Reboldi
title	wds:Q57085525-6557D12C-2CFE-4468-851E-C70D346A7D83
title	Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (en)
page(s)	wds:Q57085525-A290669F-F474-444E-8EA4-670376F651C7
page(s)	386-392
instance of	wds:Q57085525-6856A968-898C-4771-B15A-C6829C2F2FF9 wds:Q57085525-eb5f4d54-6333-47c7-b166-0cfd526b2e9a
instance of	meta-analysis scholarly article
main subject	wds:Q57085525-350B8B85-1C63-4CB9-8914-6F4555CD20B7 wds:Q57085525-92ABB872-C226-4BC5-8D46-5905BC80A887
main subject	coronary artery disease cardiovascular disease
PubMed ID	wds:Q57085525-D7F09C4D-9C2D-45EE-8FF7-D48A0D2FF831
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16009786
PubMed ID	16009786
published in	wds:Q57085525-537B3589-59D5-4F0A-9E16-879C039BAF21
published in	Hypertension
issue	wds:Q57085525-7D0A8A86-20D7-4F23-8650-1B9861847348
volume	wds:Q57085525-C008DB31-D2E6-4945-BAC3-22A2245353F2
issue	2
volume	46
DOI	wds:Q57085525-DA5AEC90-DA11-4E45-884C-7B33933E1DED
DOI	http://dx.doi.org/10.1161/01.HYP.0000174591.42889.A2
DOI	10.1161/01.HYP.0000174591.42889.A2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57085525
is cites work of	Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension Beta-blockers for hypertension Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A The metabolic vascular syndrome - guide to an individualized treatment Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis Beta-blockers for hypertension Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies Calcium channel blockers versus other classes of drugs for hypertension More about the "ARB MI paradox". Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring Beta-blockers for hypertension Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis Beta-blockers for hypertension. Managing hypertension in the elderly in light of the changes during aging Essential hypertension Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications 2007 ESH‐ESC Guidelines for the management of arterial hypertension Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes 2013 ESH/ESC Guidelines for the management of arterial hypertension Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial Blood pressure control versus atrial fibrillation management in stroke prevention Association between higher rates of cardioprotective drug use and survival in patients on dialysis The 2014 hypertension guidelines: implications for patients and practitioners in Asia Nebivolol/Hydrochlorothiazide : a new fixed-dose combination for effective simplified antihypertensive therapy Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 years Eighth Joint National Committee (JNC-8) Guidelines and the Outpatient Management of Hypertension in the African-American Population Lung Volume Reduction Surgery and Improvement of Endothelial Function and Blood Pressure in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. RAS blockers: Does sex matter/ Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure - A population study:Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602-609 Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Angiotensin receptor blockers in hypertension. New insights from Japan Management of hypertension in patients with coronary artery disease Evidence that new antihypertensives are superior to older drugs Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine. Simultaneous determination of losartan, losartan acid and amlodipine in human plasma by LC-MS/MS and its application to a human pharmacokinetic study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software